Evidence Corner

STUDIES ORGANIZED BY CATEGORIES

In the evidence corner these studies, instead of being organized by dates, are organized by other categories (drug class, surgery…).
The summaries in this section are presented in a much more reduced way.

Type of drug
Thiopurines
METHOTREXATE
INFLIXIMAB
ADALIMUMAB
certolizumab
GOLIMUMAB
VEDOLIZUMAB
USTEKINUMAB
TOFACITINIB
FILGOTINIB
UPADACITINIB
RISANKIZUMAB
MIRIKIZUMAB
OZANIMOD
ETRASIMOD

Conception, pregnancy, postpartum & lactation

2024 Thiopurine during pregnancy and intrahepatic cholestasis

Thiopurine Metabolite Shunting in Late Pregnancy Increases the Risk of Intrahepatic Cholestasis of Pregnancy in Women With Inflammatory Bowel Disease, and Can be Managed With Split Dosing

See study

2024 Updates on IBD management from preconception to pregnancy & lactation

Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation

See study

2024 pregnancy outcomes in the ozanimod program in uc, cd and multiple sclerosis

Pregnancy Outcomes in the Ozanimod Clinical Development Program in Patients With Ulcerative Colitis, Crohn’s Disease, and Relapsing Multiple Sclerosis

See study

2024 Safety of vedolizumab & ustekinumab vs antiTNF in IBD pregnant patients

Safety of vedolizumab and ustekinumab compared with anti-TNF in pregnant women with inflammatory bowel disease

See study

2023 Immunological effects & safety of rotavirus vaccination after antenatal exposure to biologics

Immunological effects and safety of live rotavirus vaccination after antenatal exposure to immunomodulatory biologic agents: a prospective cohort study from the Canadian Immunization Research Network

See study

2023 ECCO guideline on sexuality, fertility, pregnancy & lactation

European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

See guideline

2023 Tofactinib in plasma & breastmilk of women with UC

Tofacitinib concentrations in plasma and breastmilk of a lactating woman with ulcerative colitis

See study

2023 Maternal & neonatal outcomes in vedolizumab & ustekinumab exposed

Maternal and Neonatal Outcomes in Vedolizumab and Ustekinumab Exposed Pregnancies: Results from the PIANO registry

See study

2023 ovarian reserve function & IBD meta-analysis

Inflammatory bowel disease can reduce ovarian reserve function in women: A systematic review and meta-analysis

See study

2022 biologics & safety during pregnancy meta-analysis

Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis

See study

2022 ustekinumab exposure & pregnancy outcomes

Pregnancy outcomes following periconceptional or gestational exposure to ustekinumab: Review of cases reported to the manufacturer’s global safety database

See study

2022 steroid exposure & pregnancy outcomes

Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry

See study

2022 children born to mothers with IBD & infectious risk

Day Care Attendance and Infectious Complications in Children Born to Mothers With Inflammatory Bowel Disease

See study

2022 postpartum disease activity meta-analysis

Risk Factors for Postpartum Disease Activity in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

See study

2022 infliximab & adalimumab & pregnancy outcomes meta-analysis

Comparative safety of infliximab and adalimumab on pregnancy outcomes of women with inflammatory bowel diseases: a systematic review & meta-analysis

See study

2021 biologic use & risk of infantile infections meta-analysis

Biologics During Pregnancy in Women With IBD and Risk of Infantile Infections: A Systematic Review and Meta-Analysis

See study

2021 pregnancy & neonatal outcomes in exposed to biologics & thiopurines

Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease

See study

2021 adverse neonatal outcomes with Maternal IBD meta-analysis

The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

See study

2021 disease activity on pregnancy outcomes meta-analysis

The Influence of Disease Activity on Pregnancy Outcomes in Women With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

See study

2021 thiopurines & pregnancy outcomes meta-analysis

Association between Thiopurines Use and Pregnancy Outcomes in Female Patients with Inflammatory Bowel Disease: A Meta-Analysis

See study

2019 Pregnant women on biologics & infant response to vaccines

Use of Biologic Therapy by Pregnant Women with Inflammatory Bowel Disease Does Not Affect Infant Response to Vaccines

See study

2019 Preventive Health Care Among Postpartum IBD women-PIANO registry

Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry

See study

2019 Pregnancy Clinical care pathway in IBD

Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group

See study

2018 Infants breastfed by women on biologic therapy for IBD & infections

Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development

See study

2018 Pregnancy outcomes from 13-year TREAT registry

Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report

See study

2018 Flexible sigmoidoscopy in pregnant patients

Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease

See study

2017 inadequate gestational weight gain in IBD pregnant-Norway

Inadequate Gestational Weight Gain, the Hidden Link Between Maternal IBD and Adverse Pregnancy Outcomes: Results from the Norwegian Mother and Child Cohort Study

See study

2017 inadequate gestational weight gain in IBD pregnant-US

Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort

See study

2017 drug safety in IBD pregnant

Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease

See study

2017 vedolizumab during pregnancy

Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease

See study

2014 antiTNF are safe during pregnancy meta-analysis

Anti-TNFα Therapies Are Safe During Pregnancy in Women with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

See study

2014 disease activity & conception meta-analysis

Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease

See study

2007 IBD influence on pregnancy meta-analysis

A meta-analysis on the influence of inflammatory bowel disease on pregnancy

See study

Fertility, sexuality & paternal outcomes in men with IBD

2024 male fertility & reproductive outcomes- meta-analysis

Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis

See study

2023 male fertility & reproductive outcomes- meta-analysis

Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-analysis

See study

2022 Prevalence & risk factors of erectile dysfunction in IBD meta-analysis

The Prevalence and Associated Risk Factors of Erectile Dysfunction in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

See study

2021 Prevalence & risk factors for sexual dysfunction meta-analysis

Prevalence and risk factors of sexual dysfunction in patients with inflammatory bowel disease: systematic review and meta-analysis

See study

2021 paternal exposure to immunossuppressants or biologics & birth outcomes

Paternal Exposure to Immunosuppressive and/or Biologic Agents and Birth Outcomes in Patients With Immune-Mediated Inflammatory Diseases

See study

2020 Sexual function, fertility, medication safety & prostate cancer in men with IBD

Men With Inflammatory Bowel Disease: Sexual Function, Fertility, Medication Safety, and Prostate Cancer

See study

2019 Sexual dysfunction in IBD-meta-analysis

Inflammatory Bowel Diseases Were Associated With Risk of Sexual Dysfunction in Both Sexes: A Meta-analysis

See study

2019 IBD therapies & men fertility- meta-analysis

Inflammatory Bowel Disease Therapies Adversely Affect Fertility in Men- A Systematic Review and Meta-analysis

See study

Fertility, sexuality & paternal outcomes in men with IBD

Post operative recurrence in CD

UC proctitis
ULTRA SUMMARY

See summary

2020 tacro/beclo
2017 topic tacro
1980 Sulphapyridine vs 5ASA
1977 Metronidazol
1962 Steroid Suppositories
1958 Topical Hydrocortisone
1958 topical hydrocortisone II
UC proctitis

Perianal disease 

ULTRA SUMMARY

Any suggestions?

If you have any suggestion of trials or studies to add, changes or corrections of any error, feel free to write me here

New Field

Website designed by IbonDesign
Illustrations by Cristina Gros  Content creator and development Beatriz Gros